Avita Medical (AVMXY) 1.5300 $AVMXY
Avita Medical Signs Deal for Distribution in Malaysia
Marketwire Canada - Tue Jun 07, 5:00AM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 7, 2016) - Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its expansion into the Asian market with the appointment of a specialized wound care distributor for its products in Malaysia.
AVH: 6.15 (-0.31)
Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment
Marketwired - Mon May 30, 9:11PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - May 30, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Avita's Novel ReNovaCell(TM) Technology Offers Key Advantages in Skin Repigmentation of Burn Scars, When Combined With Medical Needling
Marketwired - Mon May 09, 5:00AM CDT
Data Published in Peer-Reviewed Journal Burns
AVH: 6.15 (-0.31)
Research Confirms That ReCell(R) Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment
Marketwire Canada - Thu May 05, 7:37PM CDT
UK Study Results Presented at American Burn Association (ABA) Annual Meeting
AVH: 6.15 (-0.31)
Avita Medical's ReCell Technology Demonstrated at Vitiligo Conferences in China
Marketwired - Mon May 02, 9:41PM CDT
Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds
Marketwired - Sun May 01, 9:57PM CDT
Avita Medical (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Avita Medical Announces Financial Results for Third Quarter Fiscal 2016
Marketwired - Fri Apr 29, 1:44AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced its financial results for the third quarter of fiscal 2016 which concluded on March 31, 2016.
AVH: 6.15 (-0.31)
Avita Medical -- Shareholder Letter
Marketwired - Fri Apr 29, 12:50AM CDT
Avita Medical (OTCBB: AVMXY) (ASX: AVH)
AVH: 6.15 (-0.31)
International Experts to Present on Avita Medical's Regenerative Medicine Approach at Medical Symposium, London
Marketwired - Fri Apr 22, 5:00AM CDT
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specialising in the treatment of wounds and skin defects, today announced that Mr Paul Hayes, Vascular Surgeon at Addenbrooke's Hospital, UK and Mr Harvey Chant, Vascular Surgeon, The Royal Cornwall Hospital, UK will present on their experience and data on the use of Avita's ReGenerCell(TM) in wound care at the Charing Cross International Symposium at Olympia Grand, London, UK from 26-29 April. This year's programme will focus on the challenges in the vascular and endovascular field.
AVH: 6.15 (-0.31)
International Experts Honoured With Awards at 4th Annual Skin Regeneration Symposium
Marketwired - Fri Apr 22, 5:00AM CDT
Surgeons who treated scores of victims of an explosion in last year's Taiwanese waterpark disaster, and a nurse deeply committed to treating patients and researching venous leg ulcers (VLUs) have been honoured for their contributions to advancing Avita Medical's regenerative medicine platform, the Company said today.
AVH: 6.15 (-0.31)
ReNovaCell(TM) Skin Regeneration Technology Improves Pigmentation and Appearance of Scars
Marketwired - Wed Apr 20, 7:16PM CDT
Repigmentation and scar revision by using ReNovaCell (TM) can be significantly enhanced if used in conjunction with other mainstream cosmetic surgical techniques, according to an array of findings from leading aesthetic surgeons, Avita Medical said today.
ReGenerCell(TM) Skin Regeneration Technology Decreases Size and Pain in Chronic Wounds
Marketwired - Tue Apr 19, 7:03PM CDT
Avita Medical (OTCQX: AVMXY) (ASX: AVH)
AVH: 6.15 (-0.31)
Avita Medical Signs Deal for Distribution in Malaysia
Marketwire Canada - Tue Jun 07, 5:00AM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 7, 2016) - Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its expansion into the Asian market with the appointment of a specialized wound care distributor for its products in Malaysia.
AVH: 6.15 (-0.31)
Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment
Marketwired - Mon May 30, 9:11PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - May 30, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Avita's Novel ReNovaCell(TM) Technology Offers Key Advantages in Skin Repigmentation of Burn Scars, When Combined With Medical Needling
Marketwired - Mon May 09, 5:00AM CDT
Data Published in Peer-Reviewed Journal Burns
AVH: 6.15 (-0.31)
Research Confirms That ReCell(R) Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment
Marketwire Canada - Thu May 05, 7:37PM CDT
UK Study Results Presented at American Burn Association (ABA) Annual Meeting
AVH: 6.15 (-0.31)
Avita Medical's ReCell Technology Demonstrated at Vitiligo Conferences in China
Marketwired - Mon May 02, 9:41PM CDT
Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds
Marketwired - Sun May 01, 9:57PM CDT
Avita Medical (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.15 (-0.31)
Avita Medical Announces Financial Results for Third Quarter Fiscal 2016
Marketwired - Fri Apr 29, 1:44AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced its financial results for the third quarter of fiscal 2016 which concluded on March 31, 2016.
AVH: 6.15 (-0.31)
Avita Medical -- Shareholder Letter
Marketwired - Fri Apr 29, 12:50AM CDT
Avita Medical (OTCBB: AVMXY) (ASX: AVH)
AVH: 6.15 (-0.31)
International Experts to Present on Avita Medical's Regenerative Medicine Approach at Medical Symposium, London
Marketwired - Fri Apr 22, 5:00AM CDT
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specialising in the treatment of wounds and skin defects, today announced that Mr Paul Hayes, Vascular Surgeon at Addenbrooke's Hospital, UK and Mr Harvey Chant, Vascular Surgeon, The Royal Cornwall Hospital, UK will present on their experience and data on the use of Avita's ReGenerCell(TM) in wound care at the Charing Cross International Symposium at Olympia Grand, London, UK from 26-29 April. This year's programme will focus on the challenges in the vascular and endovascular field.
AVH: 6.15 (-0.31)
International Experts Honoured With Awards at 4th Annual Skin Regeneration Symposium
Marketwired - Fri Apr 22, 5:00AM CDT
Surgeons who treated scores of victims of an explosion in last year's Taiwanese waterpark disaster, and a nurse deeply committed to treating patients and researching venous leg ulcers (VLUs) have been honoured for their contributions to advancing Avita Medical's regenerative medicine platform, the Company said today.
AVH: 6.15 (-0.31)
ReNovaCell(TM) Skin Regeneration Technology Improves Pigmentation and Appearance of Scars
Marketwired - Wed Apr 20, 7:16PM CDT
Repigmentation and scar revision by using ReNovaCell (TM) can be significantly enhanced if used in conjunction with other mainstream cosmetic surgical techniques, according to an array of findings from leading aesthetic surgeons, Avita Medical said today.
ReGenerCell(TM) Skin Regeneration Technology Decreases Size and Pain in Chronic Wounds
Marketwired - Tue Apr 19, 7:03PM CDT
Avita Medical (OTCQX: AVMXY) (ASX: AVH)
AVH: 6.15 (-0.31)
